Stocksigma LogoStocksigma Logo

Mahamaya Lifesciences Reports H1 FY27 Financial Results

For the half year ended 30th Sep'26, Mahamaya Lifesciences reported consolidated revenue from operations of ₹21,162.92 lakhs, up 29.78% YoY from ₹16,306.37

Mahamaya Lifesciences Reports H1 FY27 Financial Results

Mahamaya Lifesciences Ltd · Outcome · 13 Nov 2026, 6:48 pm

Mahamaya Lifesciences Reports H1 FY27 Financial Results For the half year ended 30th Sep'26, Mahamaya Lifesciences reported consolidated revenue from operations of ₹21,162.92 lakhs, up 29.78% YoY from ₹16,306.37 lakhs in the period ended 30th Sep'25. Consolidated net profit reached ₹1,154.87 lakhs, marking a 38.00% YoY increase compared to ₹836.88 lakhs in the previous corresponding period. Diluted EPS improved to ₹4.93 from ₹4.71 YoY. Of the ₹61.96 crore total IPO proceeds, the company has utilised ₹32.72 crore, leaving ₹29.24 crore unutilised as of 30th Sep'26.

Original exchange filing (PDF)

More announcements from Mahamaya Lifesciences Ltd

All Mahamaya Lifesciences Ltd announcements